APA (7th ed.) Citation

MR, W., PC, T., V, S., CM, W., RH, F., P, J., . . . H, G. (2011). Editor's choice: Implications of isoniazid resistance in Mycobacterium bovis Bacillus Calmette-Guérin used for immunotherapy in bladder cancer. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 52(1), 86. https://doi.org/10.1093/cid/ciq002

Chicago Style (17th ed.) Citation

MR, Watts, Taylor PC, Sintchenko V, Whelan CM, Farnsworth RH, Jones P, Jelfs P, Carr D, and Goldberg H. "Editor's Choice: Implications of Isoniazid Resistance in Mycobacterium Bovis Bacillus Calmette-Guérin Used for Immunotherapy in Bladder Cancer." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 52, no. 1 (2011): 86. https://doi.org/10.1093/cid/ciq002.

MLA (9th ed.) Citation

MR, Watts, et al. "Editor's Choice: Implications of Isoniazid Resistance in Mycobacterium Bovis Bacillus Calmette-Guérin Used for Immunotherapy in Bladder Cancer." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 52, no. 1, 2011, p. 86, https://doi.org/10.1093/cid/ciq002.